openPR Logo

Press Releases from Exactitude Consultancy (22221 total)

Pyoderma Gangrenosum (PG) Market the market is expected to reach USD 550-650 mil …

Market Overview The Pyoderma Gangrenosum (PG) market is expanding gradually as awareness increases about this rare, painful, and rapidly progressive neutrophilic dermatosis. PG commonly presents as

Pollen Allergy Market is expected to reach USD 9.0-10.0 billion by 2032, registe …

Market Overview The Pollen Allergy market is growing steadily as allergic rhinitis, asthma, and seasonal hypersensitivity reactions become increasingly prevalent worldwide. Rising pollution, climate-driven changes in

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market is Projected to reach USD …

Market Overview The Neuromyelitis Optica Spectrum Disorder (NMOSD) market is expanding significantly due to improved diagnostic capabilities, rising awareness of autoimmune CNS disorders, and rapid adoption

Hemophilia A Market is projected to reach USD 19.84 billion by 2034

The global Hemophilia A Market was valued at USD 11.26 billion in 2024 and is projected to reach USD 19.84 billion by 2034, expanding at

Moderate to Severe Plaque Psoriasis Market is expected to reach USD 43-48 billio …

Market Overview The Moderate to Severe Plaque Psoriasis market continues to grow robustly, supported by rapid adoption of biologics, targeted oral therapies, and personalized treatment pathways.

Essential Thrombocythemia (ET) Market is projected to reach USD 1.52 billion by …

The global Essential Thrombocythemia Market was valued at USD 742 million in 2024 and is projected to reach USD 1.52 billion by 2034, expanding at

Coagulation Factor Deficiency Market is projected to reach USD 16.87 billion by …

The global Coagulation Factor Deficiency Market was valued at USD 9.42 billion in 2024 and is projected to reach USD 16.87 billion by 2034, growing

Mild to Moderate Plaque Psoriasis Market is Projected to reach USD 14-16 billion …

Market Overview The Mild to Moderate Plaque Psoriasis market is expanding steadily as patient awareness grows, diagnosis rates improve, and demand increases for effective topical and

Beta Thalassemia Market is projected to reach USD 10.72 billion by 2034

The global Beta Thalassemia Market was valued at USD 5.31 billion in 2024 and is projected to reach USD 10.72 billion by 2034, growing at

Aplastic Anemia Market is projected to reach USD 2.11 billion by 2034

The global Aplastic Anemia Market was valued at USD 1.07 billion in 2024 and is projected to reach USD 2.11 billion by 2034, expanding at

House Dust Mite Allergy Market is Expected to reach USD 2.8-3.2 billion by 2032, …

Market Overview The House Dust Mite Allergy market is growing steadily due to increasing global allergy prevalence, rising pollution levels, and expanded access to immunotherapy and

Alpha Thalassemia Market is projected to reach USD 1.82 billion by 2034

The global Alpha Thalassemia Market was valued at USD 884 million in 2024 and is projected to reach USD 1.82 billion by 2034, growing at

Pancreatic Ductal Adenocarcinoma (PDAC) Market is Projected to reach USD 22-25 b …

Market Overview The Pancreatic Ductal Adenocarcinoma (PDAC) market is expanding rapidly due to the increasing global incidence of pancreatic cancer, late-stage diagnosis patterns, limited treatment success

Hidradenitis Suppurativa (HS) Patient Pool Analysis Market is Projected to reach …

Market Overview The Hidradenitis Suppurativa (HS) patient pool is expanding globally due to rising awareness, improved dermatology access, and increased diagnosis rates of this chronic, painful,

Juvenile Idiopathic Arthritis (JIA) Market is Expected to reach USD 3.2-3.6 bill …

Market Overview The Juvenile Idiopathic Arthritis (JIA) market is expanding steadily as awareness of pediatric autoimmune diseases increases and demand rises for biologic and targeted therapies.

Hemophilia Market is projected to reach USD 25.96 billion by 2034

The global Hemophilia Market was valued at USD 14.82 billion in 2024 and is projected to reach USD 25.96 billion by 2034, growing at a

Oligodendroglioma Market is projected to reach USD 867 million by 2034

The global Oligodendroglioma Market was valued at USD 412 million in 2024 and is projected to reach USD 867 million by 2034, growing at a

Dermatome Devices Market Projected to reach USD 230-260 million by 2032, registe …

Market Overview The Dermatome Devices market is growing steadily due to increasing demand for skin grafting procedures, rising incidence of burns and traumatic injuries, and ongoing

Nasopharyngeal Neoplasms Market is projected to reach USD 4.37 billion by 2034

The global Nasopharyngeal Neoplasms Market was valued at USD 2.14 billion in 2024 and is projected to reach USD 4.37 billion by 2034, growing at

Ovarian Clear Cell Carcinoma (OCCC) Market is expected to reach USD 738 million …

The global Ovarian Clear Cell Carcinoma (OCCC) Market was valued at USD 356 million in 2024 and is expected to reach USD 738 million by

Warts Market is Expected to reach USD 3.0-3.3 billion by 2032, reflecting a CAGR …

Market Overview The global Warts market is expanding steadily as demand increases for dermatology treatments targeting HPV-related skin growths. Warts-caused by human papillomavirus (HPV) infection-are highly

Oncolytic Adenovirus Market is projected to reach USD 389 million by 2034

The global Oncolytic Adenovirus Market was valued at USD 124 million in 2024 and is projected to reach USD 389 million by 2034, growing at

Idiopathic Inflammatory Myositis (IIM) Market is projected to reach USD 2.43 bil …

The global Idiopathic Inflammatory Myositis (IIM) Market was valued at USD 1.18 billion in 2024 and is projected to reach USD 2.43 billion by 2034,

Varicose Ulcer Market is projected to reach USD 4.5-5.0 billion by 2032, registe …

Market Overview The Varicose Ulcer market is expanding steadily due to the rising global prevalence of chronic venous insufficiency (CVI), aging populations, diabetes, and obesity-major contributors

Soft Tissue Defect Market is projected to reach USD 7.0-8.0 billion by 2032, reg …

Market Overview The Soft Tissue Defect market is expanding rapidly due to rising surgical volumes, increasing traumatic injuries, growing prevalence of chronic wounds, and advancements in

Acne Vulgaris Market is projected to reach USD 16-18 billion by 2032, registerin …

Market Overview The Acne Vulgaris market continues to grow as dermatology demand rises globally, driven by increasing adolescent and adult acne prevalence, expanding cosmetic dermatology engagement,

Hematopoietic Stem Cell Transplantation (HSCT) Market is projected to reach USD …

The global Hematopoietic Stem Cell Transplantation (HSCT) Market was valued at USD 14.27 billion in 2024 and is projected to reach USD 29.84 billion by

Guillain-Barré Syndrome (GBS) Market is projected to reach USD 1.39 billion by …

The global Guillain-Barré Syndrome (GBS) Market was valued at USD 684 million in 2024 and is projected to reach USD 1.39 billion by 2034, expanding

Graft-Versus-Host Disease (GVHD) Market is projected to reach USD 8.41 billion b …

The global Graft-Versus-Host Disease (GVHD) Market was valued at USD 3.72 billion in 2024 and is projected to reach USD 8.41 billion by 2034, expanding

Cytokine Release Syndrome (CRS) Market is projected to reach USD 3.12 billion by …

The global Cytokine Release Syndrome (CRS) Market was valued at USD 1.43 billion in 2024 and is projected to reach USD 3.12 billion by 2034,

Vitiligo Market is Expected to reach USD 2.3-2.6 billion by 2032, reflecting a C …

Market Overview The global Vitiligo market is growing steadily as demand increases for advanced dermatology treatments, targeted immunotherapies, and non-invasive pigmentation technologies. Vitiligo is an acquired

Cutaneous Lupus Erythematosus (CLE) Market is Expected to reach USD 1.30-1.45 bi …

Market Overview The Cutaneous Lupus Erythematosus (CLE) market is growing steadily as recognition of autoimmune skin disorders improves and demand for safer, targeted therapies increases. CLE

Celiac Disease Market is projected to reach USD 10.14 billion by 2034

The global Celiac Disease Market was valued at USD 4.62 billion in 2024 and is projected to reach USD 10.14 billion by 2034, growing at

Hepatic Impairment Market Registering a CAGR of 4.5%-5.5% during the forecast pe …

Market Overview The Hepatic Impairment market is growing steadily as the global burden of liver diseases increases, particularly cirrhosis, hepatitis, alcoholic liver disease, and drug-induced liver

Febrile Neutropenia Market is projected to reach USD 15-17 billion by 2032, regi …

Market Overview The Febrile Neutropenia market is expanding steadily as global cancer incidence rises and the use of chemotherapy continues to increase. Febrile neutropenia is a

Behçet's Disease Market is projected to reach USD 941 million by 2034

The global Behçet's Disease Market was valued at USD 482 million in 2024 and is projected to reach USD 941 million by 2034, expanding at

Rheumatoid Arthritis (RA) Market is Expected to reach USD 95-105 billion by 2032 …

Market Overview The Rheumatoid Arthritis (RA) market continues to grow steadily as the global burden of autoimmune diseases rises and demand increases for advanced biologic and

Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Market is projected to reach US …

The global Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Market was valued at USD 241 million in 2024 and is projected to reach USD 468 million by

IgA Nephropathy (IgAN) Market Reflecting a CAGR of 11%-13% 2024 -2032

Market Overview The IgA Nephropathy (IgAN) market is expanding rapidly as diagnostic capabilities improve and new targeted therapies emerge for this chronic immune-mediated kidney disease. IgAN,

Eosinophilia Market is projected to reach USD 2.68 billion by 2034

The global Eosinophilia Market was valued at USD 1.36 billion in 2024 and is projected to reach USD 2.68 billion by 2034, expanding at a

Cutaneous Lupus Erythematosus (CLE) Market to reach USD 1.30-1.45 billion by 203 …

Market Overview The Cutaneous Lupus Erythematosus (CLE) market is growing steadily as awareness of autoimmune skin disorders increases, diagnostic accuracy improves, and new targeted immunotherapies enter

Cough in IPF Patient Pool Analysis Market for cough in IPF was valued at USD 90- …

Market Overview Cough associated with Idiopathic Pulmonary Fibrosis (IPF) represents a significant unmet clinical need, as over 70%-85% of IPF patients experience persistent, debilitating cough that

Cryoglobulinemia Market is projected to reach USD 1.92 billion by 2034

The global Cryoglobulinemia Market was valued at USD 991 million in 2024 and is projected to reach USD 1.92 billion by 2034, growing at a

Wilson Disease Market Valued at USD 550-600 million in 2024 and is expected to r …

Market Overview The Wilson Disease market is expanding steadily due to improved genetic testing, rising disease awareness, and advancements in copper-chelating therapy and targeted drug development.

Beta Thalassemia Market is projected to reach USD 3.96 billion by 2034

The global Beta Thalassemia Market was valued at USD 1.82 billion in 2024 and is projected to reach USD 3.96 billion by 2034, growing at

Von Hippel-Lindau (VHL) Disease Market is projected to reach USD 1.1-1.3 billion …

Market Overview The Von Hippel-Lindau (VHL) Disease market is expanding due to growing adoption of targeted therapies, improved genetic screening, and rising awareness of hereditary cancer

Antiphospholipid Syndrome (APS) Market is projected to reach USD 2.21 billion by …

The global Antiphospholipid Syndrome (APS) Market was valued at USD 1.14 billion in 2024 and is projected to reach USD 2.21 billion by 2034, expanding

Stargardt Disease Market was valued at USD 120-150 million in 2024

Market Overview The Stargardt Disease market is expanding steadily as advancements in retinal imaging, genetic testing, and gene-therapy research accelerate therapeutic development. Stargardt Disease, the most

Pseudoxanthoma Elasticum (PXE) Market Valued at USD 40-50 million in 2024

Market Overview The Pseudoxanthoma Elasticum (PXE) market is growing gradually as awareness of rare genetic disorders increases, diagnostic capabilities improve, and research expands into mineralization inhibitors

Anemia Market is projected to reach USD 49.73 billion by 2034

The global Anemia Market was valued at USD 26.85 billion in 2024 and is projected to reach USD 49.73 billion by 2034, growing at a

Go To Page:    1 2 3 4 5 6 7 8 9 10 101 102 103 104 105 106 107 108 109 110